XML 49 R42.htm IDEA: XBRL DOCUMENT v3.25.3

Net Income (Loss) Per Share (Tables)

9 Months Ended

Sep. 30, 2025

Earnings Per Share [Abstract]

Computation of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders

The following table summarizes the computation of basic and diluted net income (loss) per share attributable to common stockholders of the Company:

		Three Months Ended September 30,								Nine Months Ended September 30,
		2025				2024				2025				2024
Net income (loss)		$	8,378			$	(10,564	)		$	7,375			$	(34,091	)
Convertible and Redeemable Series A-2 Preferred Stock dividend			—				(2,750	)			(4,150	)			(8,314	)
Net income (loss) attributable to common stockholders			8,378				(13,314	)			3,225				(42,405	)
Weighted average common shares outstanding
Weighted average common shares outstanding - basic			35,300				34,242				35,003				32,647
Effect of dilutive stock options			1,390				—				1,243				—
Effect of dilutive restricted stock			3,245				—				3,301				—
Diluted			39,935				34,242				39,547				32,647
Net income (loss) per share attributable to common stockholders
Basic		$	0.24			$	(0.39	)		$	0.09			$	(1.30	)
Diluted		$	0.21			$	(0.39	)		$	0.08			$	(1.30	)

Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share Attributable to Common Stockholders

The following common stock equivalents were excluded from the calculation of diluted net income (loss) per share attributable to common stockholders for the nine months ended September 30, 2025 and the three and nine months ended September 30, 2024 because their effect would have been anti-dilutive:

		September 30,
		2025(1)				2024(1)
Stock options			—				3,059,061
Restricted stock			—				2,629,026
Series A-2 Preferred Stock			5,353,478				4,448,404
SARs(2)			—				3,000,000

_____________________________

(1) Includes 2,950,220 and 7,891,144 common stock equivalents that are out of the money as of September 30, 2025 and September 30, 2024, respectively.

(2) 2021 Performance SARs were cancelled effective as of December 31, 2024.

X

- References

No definition available.

+ Details

Name:	us-gaap_EarningsPerShareAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

+ Details

Name:	us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration